Viewing nowZarotan 50 mg Tablet (Losartan Potassium)
Losartan Potassium 50mg
Tablet · Prescription medication
Seoul Pharmaceutical Co., Ltd.

MFDS item code 200703082 · Notified 2007.03.14
Treatment of hypertension and kidney disease in patients with type 2 diabetes accompanied by hypertension
This medication is used for the treatment of hypertension, especially helping in the treatment of kidney disease in patients with type 2 diabetes accompanied by hypertension. It stabilizes blood pressure and contributes to the protection of kidney function, thus effectively used for the treatment of hypertension and diabetes-related kidney complications.
This medicine may be taken with or without food, but it is recommended that it be taken at the same time each day. 1. Hypertension The recommended initial and maintenance dose is 50 mg of losartan potassium orally once daily. The maximum blood pressure-lowering effect is achieved 3 ∼ 6 weeks after starting treatment. If the therapeutic effect is insufficient, the same dose may be divided and administered orally twice daily, or the dose may be increased to up to 100 mg once daily, if necessary. If blood pressure is not controlled with this medicine alone, it may be administered in combination with other antihypertensive agents (e.g., a low-dose diuretic). An additive effect has been observed when administered in combination with hydrochlorothiazide. 2. Nephropathy in patients with type 2 diabetes and hypertension The usual adult dose is 50 mg of this medicine once daily. Depending on blood pressure, the dose may be increased to up to 100 mg once daily. However, an initial dose of 25 mg is recommended for patients at risk of excessive blood pressure reduction. This medicine may be administered in combination with insulin and commonly used antihyperglycemic agents (e.g., sulfonylureas, glitazones, glucosidase inhibitors). 3. Special patient populations No initial dose adjustment is necessary in elderly patients 75 years of age or younger. For elderly patients over 75 years of age, an initial dose of 25 mg of this medicine once daily is recommended. Creatinine clearance 20 ∼ 50 mL/min: No initial dose adjustment is necessary. Creatinine clearance < 20 mL/min and patients undergoing dialysis: An initial dose of 25 mg of this medicine once daily is recommended. For patients who may have intravascular volume depletion (e.g., patients being treated with diuretics), an initial dose of 25 mg of this medicine once daily is recommended (see Precautions for Use). A lower dose should be considered in patients with a history of hepatic impairment. Do not administer to patients with severe hepatic impairment.
Children and adolescents aged 6 years and older who weigh 20 kg or more but less than 50 kg and are able to swallow tablets: The recommended dose is 25 mg of this medicine once daily, which may be increased to a maximum of 50mg once daily depending on the patient's blood pressure response. Children and adolescents aged 6 years and older who weigh 50 kg or more: The usual recommended dose is 50 mg of this medicine once daily, which may be increased to a maximum of 100 mg once daily depending on the patient's blood pressure response. Pediatric patients under 6 years of age: Not recommended. Pediatric patients with a glomerular filtration rate below 30 mL/min/1.73㎡: Not recommended. Pediatric patients with hepatic impairment: Not recommended.
This medication can cause serious harm or even death to the fetus when taken during pregnancy, especially in the second and third trimesters, so it should not be used by women who are pregnant or may become pregnant. It should not be administered to patients with severely impaired liver function, certain genetic disorders, or a history of angioedema. Special caution is required when administering this medication to the elderly, patients with impaired kidney function, patients with hyperkalemia, and patients with heart disease. During the course of this medication, side effects such as dizziness, muscle cramps, cough, and indigestion may occur; if symptoms are severe, consult a physician. Interactions may occur if this medication is taken with other antihypertensive drugs, potassium-sparing diuretics, or non-steroidal anti-inflammatory drugs, so it is crucial to inform healthcare providers of all current medications. Since this medication can pose risks to the fetus during pregnancy, it should be discontinued immediately if pregnancy is confirmed, and a physician should be consulted. Women who are breastfeeding should avoid using this medication if possible since it may be excreted in breast milk; if unavoidable, breastfeeding should be suspended. This medication should not be administered to children, especially those under the age of 6 or those with severely impaired kidney function. While taking this medication, blood pressure, kidney function, and electrolyte levels should be monitored regularly to check for abnormalities, especially in the elderly or those with kidney impairment. During treatment, sudden hypotension, loss of consciousness, and severe allergic reactions may occur, and if such symptoms are present, healthcare providers should be notified immediately. In case of overdose, hypotension and bradycardia may occur, so the dosage should be carefully adhered to and prompt treatment sought in case of abnormal symptoms. This medication should be stored out of reach of children, and caution should be exercised as transferring it to other containers may affect product quality.
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air and moisture, so it must be stored in a tightly sealed container. Additionally, it should be kept in a location that avoids extreme heat or cold, ideally at room temperature between 1 to 30 degrees Celsius.
White oval film-coated tablet
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowLosartan Potassium 50mg
Tablet · Prescription medication
Seoul Pharmaceutical Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
DaeWon Pharmaceutical Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
Korea United Pharm, Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
HK Inno.N Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
IYON Pharmaceuticals Co., Ltd.
Losartan Potassium
Prescription medication
JW ShinYak Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
Kukje Pharmaceutical Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
Celltrion Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.